SciELO - Scientific Electronic Library Online

 
vol.66 número1Evaluación de los conceptos diagnósticos y de manejo de la anafilaxia en médicos no alergólogos de ColombiaSensibilidad y especificidad de la prueba epicutánea modificada en el diagnóstico de alergia respiratoria a Dermatophagoides pteronyssinus índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista alergia México

versión On-line ISSN 2448-9190

Resumen

AYALA, María del Carmen et al. Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience. Rev. alerg. Méx. [online]. 2019, vol.66, n.1, pp.27-37. ISSN 2448-9190.  https://doi.org/10.29262/ram.v66i1.531.

Background:

Dialyzable leukocyte extracts (DLE) have been used to treat several cellular immunodeficiency.

Objective:

To review the experience of a tertiary hospital in the use of DLE for the treatment of recurrent or severe infections in children with acquired cellular immunodeficiency not due to HIV.

Methods:

We reviewed the medical records of all children who received treatment with EDL of human or bovine origin between 1986 and 2000 to detect recurrent or severe infections without response to a specific antimicrobial therapy and with a quantitative or qualitative deficit in the cellular immune response. The dose of DLE was adjusted according to the percentage of T lymphocytes; the evolution of the patient was evaluated retrospectively for 5 years, the immune response was evaluated by subpopulation of lymphocytes and intradermal tests and inhibition of the leukocyte migration assay (LIF) to PPD, coccidioidin, varidase and candidin.

Results:

150 children received DLE, age 7.0 ± 5.9 years. The most frequent indications included upper respiratory tract (71%), lower respiratory tract (43%), gastrointestinal tract (15%), urinary tract (15%) and neurological infections (4%) and coccidioidomycosis (3%). After starting the DLE, the numbers of T lymphocytes, LIF to PPD and varidase (> 20%) and the intradermal induration of the test increased (p <0.001). In 6 patients (4%) recurrences of respiratory and gastrointestinal tract infections were observed, which resolved, no adverse effects attributable to the DLE were reported.

Conclusions:

The use of DLE for recurrent or severe infectious processes in children with cellular immune deficit improved the clinical evolution and the immunological parameters evaluated without adverse effects attributable to their use.

Palabras llave : Cellular immunodeficiency; Extracted dialyzable leukocytes; Transfer factors; Immunomodulatory; Immunotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )